Cite
SEMA4D compromises blood–brain barrier, activates microglia, and inhibits remyelination in neurodegenerative disease
MLA
Sebold Torno, et al. “SEMA4D Compromises Blood–brain Barrier, Activates Microglia, and Inhibits Remyelination in Neurodegenerative Disease.” Neurobiology of Disease, pp. 254–68. EBSCOhost, https://doi.org/10.1016/j.nbd.2014.10.008. Accessed 14 Dec. 2024.
APA
Sebold Torno, Jennifer Seils, Crystal Mallow, Chad A. Cornelius, Elizabeth E. Evans, Janaki Veeraraghavan, Ernest S. Smith, Mark Paris, Gareth R. John, Alan S. Jonason, Ekaterina Klimatcheva, Michael A. Doherty, Trinh Pham, John E. Leonard, Maurice Zauderer, William J. Bowers, Terrence L. Fisher, Renee Kirk, Alan Howell, … Nicola Marchi. (n.d.). SEMA4D compromises blood–brain barrier, activates microglia, and inhibits remyelination in neurodegenerative disease. Neurobiology of Disease, 254–268. https://doi.org/10.1016/j.nbd.2014.10.008
Chicago
Sebold Torno, Jennifer Seils, Crystal Mallow, Chad A. Cornelius, Elizabeth E. Evans, Janaki Veeraraghavan, Ernest S. Smith, et al. 2024. “SEMA4D Compromises Blood–brain Barrier, Activates Microglia, and Inhibits Remyelination in Neurodegenerative Disease.” Neurobiology of Disease, 254–68. Accessed December 14. doi:10.1016/j.nbd.2014.10.008.